Is synchronous hepatectomy and splenectomy superior to hepatectomy alone for selected patients with hepatocellular carcinoma and clinically significant portal hypertension?-Reference-Cited by-同舟云学术

Is synchronous hepatectomy and splenectomy superior to hepatectomy alone for selected patients with hepatocellular carcinoma and clinically significant portal hypertension?

Published:2019-06-11 Issue: Volume: Page:
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Xie Xian‐Long¹,Liu Xu²^ORCID,Ou Jie³

Affiliation:

1. Intensive Care UnitAffiliated Tumor Hospital of Guangxi Medical UniversityNanning China

2. Department of Hepatobiliary SurgeryAffiliated Tumor Hospital of Guangxi Medical UniversityNanning China

3. Department of Traditional Chinese MedicineAffiliated Tumor Hospital of Guangxi Medical UniversityNanning China

Funder

Graduate Course Construction Project of Guangxi Medical University

Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.25577

Reference12 articles.

1. Synchronous hepatectomy and splenectomy vs hepatectomy for selected patients with hepatocellular carcinoma and clinically significant portal hypertension: A systematic review and meta‐analysis

2. Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis

3. A meta‐analysis of the efficacy of combined hepatectomy and splenectomy in treating hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism;Qiao Q;Chin J Hepatobiliary Surg,2011

4. Prevalence of portal or splenic vein thrombosis in cirrhotic patients after splenectomy: a systematic review and meta‐analysis of observational studies;Liu X;Int J Clin Exp Med,2016

5. [Long‐term effect of united hepatectomy and splenectomy on treatment of hepatocellular carcinoma complicated with cirrhosis and hypersplenism];Cai JQ;Zhonghua Yi Xue Za Zhi,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases;Heliyon;2022-12

2. The Benefits of Radical Treatments with Synchronous Splenectomy for Patients with Hepatocellular Carcinoma and Portal Hypertension;Cancers;2022-06-28

3. Does splenectomy significantly improve the prognosis of hepatocellular carcinoma patients with hypersplenism? A systematic review and meta-analysis;Annals of Translational Medicine;2021-04